Hersima 440 mg Injection
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Hersima 440 mg Injection

Hersima 440 mg Injection

Hersima 440 mg Injection contains trastuzumab, a targeted anticancer medicine used for certain HER2-positive cancers. It is supplied as a 440 mg vial and is administered by a qualified healthcare professional. It is mainly used in the treatment of HER2-positive breast and stomach cancers.

BUY NOW

Category

Trastuzumab is a monoclonal antibody that specifically targets the HER2 protein found in certain cancer cells. By binding to HER2, it blocks growth signals and helps the immune system identify and destroy targeted cancer cells. Hersima may be used alone or with chemotherapy and other cancer treatments depending on the clinical indication. The treatment schedule and dose are determined by the treating oncologist, with regular monitoring including heart function during therapy.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 20 mL
Manufacturer Alkem Laboratories Ltd

Product Also Known As

Hersima 440 mg Injection, Trastuzumab 440 mg Injection, Hersima Trastuzumab Injection, Trastuzumab Anticancer Injection, Anti-HER2 Monoclonal Antibody Injection, HER2-Positive Cancer Injection